📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Radian Group Inc., together with its subsidiaries, provides mortgage insurance in the United States.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding RDN

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Steve Cohen Point72 Asset Management	520.0K	$17.2M	0.02%	Mar 2026
Jim Simons Renaissance Technologies LLC	133.7K	$4.4M	0.01%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Strong positive language throughout: 'strong performance', 'increased book value per share by 12%', 'net income of $142M', 'delivering a return on equity of 12.5%', 'strong credit performance with cures exceeding new defaults'. Direct answers to analyst questions, no hedging or defensiveness.

Q3 2025

Confident Specific

Management repeatedly used terms like 'strong performance', 'excellent results', 'record high in-force portfolio', and provided specific figures such as 13.4% ROE for continuing operations, $281B in-force, and $1.9B PMIERs cushion. They gave detailed timelines and dollar amounts for the Inigo acquisition and divestitures.

Q4 2025

Confident Specific

Management uses strongly positive language: 'strong quarter,' 'outstanding year,' 'defining milestone,' 'exciting new chapter.' They provide specific metrics (15.9B NIW, 283B IIF, 795M dividends from Guaranty, 576M returned to stockholders) and future expectations (stable premium yield, at least 600M dividends in 2026). The tone is forward-looking and assured about the strategic transformation.

Q1 2026 latest

Confident Specific

Management used definitive language like 'strong start', 'off to a strong start', 'meaningfully contributed', 'consistent with our expectations'. They cited exact figures (22% EPS growth, 130bps ROE increase, $50M buyback) and reinforced repeated successful execution of the Inigo acquisition and capital return plan.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis appears stronger after this call. The immediate financial contribution from Inigo (two months) boosted earnings per share 22% and ROE 130bps, validating the acquisition's strategic logic. The MI segment remains resilient with strong persistency and favorable credit trends, while capital returns resumed quickly post-deal. Key watch items for next quarter: (1) Inigo's full-quarter contribution (rather than two months) and how the combined ratio tracks against the 85% reported; (2) the pace of credit facility repayment and further share repurchases; (3) any early signs of rate softening in specialty lines that might pressure margins; (4) progress on the divestitures of held-for-sale entities. The company's discipline in capital management and underwriting gives confidence, but the lack of explicit forward guidance on specialty earnings leaves some uncertainty.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED Radian closes Inigo; Q1 adj. EPS $1.27, ROE 14.7%

Revenue & Profitability

First-quarter GAAP net income from continuing operations was $129 million ($0.93 per share), with a return on equity of 10.8%. Adjusted net operating earnings per share grew 22% year-over-year to $1.27, and adjusted net operating return on equity was 14.7%. Total revenues increased 58% to $466 million, and book value per share rose 10% to $35.67.

Outlook

Management expressed confidence in the combined company's earnings power and capital flexibility. In mortgage insurance, favorable cure trends continued beyond the quarter. In specialty insurance, the market is more competitive, particularly in property lines, but underwriting profitability remains strong. No specific macro headwinds were cited, but the softening market was noted.

Growth Drivers

Mortgage new insurance written rose 42% year-over-year to $13.5 billion. The specialty segment provides access to a large, global, and non-correlated market with diverse product lines. Capital is dynamically allocated to the highest risk-adjusted return opportunities across both segments, supporting value-driven growth.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

The mortgage segment expense ratio improved to 20% from 21% a year ago, with operating expenses down 6%. The specialty segment reported a net combined ratio of 85% and a net expense ratio of 33% for the two months owned. Favorable development from prior-period defaults was $36 million in mortgage and $13 million in specialty. Management expects variability in the specialty combined ratio over time.

Key Risks

Risks flagged include competitive pricing pressure in specialty lines, variability in loss experience, natural catastrophe losses, and seasonality. Mortgage claim severity has been increasing due to higher loan balances and changes in home price appreciation benefits. Forward-looking statements are subject to risks and uncertainties detailed in SEC filings.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-08-06

Second quarter results reflect a successful transformation into a global multi-line insurer, with revenues up 93% year-over-year and strong contributions from both mortgage and specialty segments. Specialty insurance now accounts for about half of revenues, though market softening and Middle East reserving impacted combined ratios.

Q1 2026 Q1 2026 2026-05-07

First quarter results reflect the successful integration of Inigo, driving 58% revenue growth and a 22% increase in adjusted operating EPS year-over-year. Mortgage and specialty segments both delivered strong performance, with disciplined capital management and resumed share repurchases.

Q4 2025 Q4 2025 2026-02-19

Q4 and full year 2025 saw record mortgage insurance in force, strong earnings, and a 13% increase in book value per share. The Inigo acquisition, funded with internal capital, is expected to double revenues and be accretive to EPS, while divestitures and share repurchases remain on track.

Q3 2025 Q3 2025 2025-11-05

Strong Q3 results driven by a robust mortgage insurance portfolio and disciplined capital management. Strategic transformation includes divesting non-core businesses and acquiring Inigo, expected to boost ROE and expand the addressable market significantly.

Q2 2025 Q2 2025 2025-07-31

Q2 saw net income of $142M, 12% book value per share growth, and strong credit performance, with stable premium yields and robust capital returns. Share repurchases and dividends exceeded $500M in H1, while operating expenses are projected to decrease 8% in 2025.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.